Merck M&A chief expects more deal flow as Keytruda patent cliff nears
Merck’s M&A chief said he expects “a lot more deal flow” as the Keytruda patent cliff approaches.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.